Page last updated: 2024-10-25

chlorpropamide and Necrobiosis Lipoidica

chlorpropamide has been researched along with Necrobiosis Lipoidica in 1 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Necrobiosis Lipoidica: A degenerative disease of the dermal connective tissue characterized by the development of erythematous papules or nodules in the pretibial area. The papules form plaques covered with telangiectatic vessels. More than half of the affected patients have diabetes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GAETHE, G1

Other Studies

1 other study available for chlorpropamide and Necrobiosis Lipoidica

ArticleYear
NECROBIOSIS LIPOIDICA DIABETICORUM OF THE SCALP.
    Archives of dermatology, 1964, Volume: 89

    Topics: Black People; Chlorpropamide; Diabetes Mellitus; Diet, Diabetic; Humans; Necrobiosis Lipoidica; Scal

1964